Summary
Sinus node disease (SND) encompasses a number of abnormalities of sinus impulse generation and transmission within the atria and may lead to both bradyarrhythmias and tachycardias. Such abnormalities may be due to primary atrial electrophysiological abnormalities, or be secondary to drugs or abnormal autonomic control. The diagnosis may be readily established from the surface ECG or Holter recordings in many cases, but invasive electrophysiological study or assessment of the effects of autonomic blockade may be required in symptomatic patients in whom the diagnosis is suspected but not confirmed by simple electrocardiographic monitoring.
Treatment should be restricted to those patients in whom clear correlation between symptoms and electrocardiographic or electrophysiological abnormalities has been established. Although a number of pharmacological agents have been assessed, the treatment of bradyarrhythmias should be permanent pacing. There is now substantial evidence that physiological (atrial or dual chamber) pacing reduces atrial arrhythmias, systemic embolisation, progression to heart failure and mortality, compared to single chamber ventricular pacing. Antiarrhythmic therapy may be required to control atrial tachyarrhythmias if they persist following pacing. In patients with uncontrolled atrial arrhythmias, especially those with ventricular pacemakers, long term oral anticoagulation should be considered to reduce the risk of systemic embolisation which is a common complication in patients with the bradycardia/tachycardia syndrome.
Similar content being viewed by others
References
Alpert M, Curtis J, Sanfelippo J, Flaker G, Walls J, et al. Comparative survival following permanent ventricular and dual chamber pacing for patients with chronic symptomatic sinus node dysfunction with and without congestive heart failure. American Heart Journal 113: 958–965, 1987
Becker A. General comments. In Bonke F (Ed.) The sinus node. Structure, function and clinical relevance, pp. 212–222, Martinus Nijhoff, The Hague, 1978
Benditt D, Benson D, Kreitt J, Dunnigan A, Pritzker M, et al. Electrophysiologic effect of theophylline in young patients with recurrent symptomatic bradyarrhythmias. American Journal of Cardiology 52: 1223–1229, 1983
Benedini G, Cuccia C, Bolognesi R, Affatato A, Gallo G, et al. Value of purinergic compounds in assessing sinus node dysfunction in man: a new diagnostic method. European Heart Journal 5: 394–403, 1984
Bianconi L, Boccadamo R, DiFlorio A, Carpino A, Catalano F, et al. Atrial versus ventricular stimulation in sick sinus syndrome: effects on morbidity and mortality. Abstract no. 233 Pacing and Clinical Electrophysiology 12: 1236, 1989
Breithardt G, Seipel L, Wiebringhaus E, Loogen F. Effect of verapamil on sinus node function in patients with normal and abnormal sinus node function. Abstract no. 66. Circulation 54 (Suppl. II): 19, 1976
Bolognesi R, Benedini G, Ferrari R, Visioli O. Inhibitory effect of acute and chronic administration of digitalis on the sick sinus node. European Heart Journal 7: 334–340, 1986
Camm A. Cardiac electrophysiology of four new antiarrhythmic drugs — encainide, flecainide, lorcainide and tocainide. European Heart Journal 5 (Suppl. B): 75–79, 1984
Chamberlain-Webber R, Petersen M, Sutton R. Use of flecainide in the identification of sick sinus syndrome in patients with normal corrected sinus node recovery times. Abstract no. 56 Pacing and Clinical Electrophysiology 14: 631, 1991
Dreifus L, Fisch C, Griffin J, Gillette P, Mason J, et al. Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. A report of the American College of Cardiology/ American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovacular Procedures (Committee on Pacemaker Implantation). Circulation 84: 455–467, 1991
Engel T, Leddy C, del Gonzalez A, Meister S, Frankl W. Electrophysiologic effects of hydralazine on sinoatrial function in patients with sick sinus syndrome. American Journal of Cardiology 41: 763–769, 1978
Engel T, Luck J. Histamine2 receptor antagonism by cimetidine and sinus node function. New England Journal of Medicine 301: 591–592, 1979
Fairfax A, Lambert C, Leatham A. Systemic embolisation in chronic sinoatrial disorder. New England Journal of Medicine 295: 190–192, 1976
Feleke E, Ryden L, Smedgard P, Westerling S. Prenalterol in symptomatic sinus node dysfunction. American Heart Journal 109: 185–187, 1985
Goodman D, Rossen R, Ingham R, Rider A, Harrison D. Sinus node function in the denervated human heart: effect of digitalis. British Heart Journal 37: 612–618, 1975
Haywood G, Ward J, Ward D, Camm A. Atrioventricular Wenckebach point and progression to atrioventricular block in sinoatrial disease. Pacing and Clinical Electrophysiology 13: 2054–2058, 1990
Hellestrand K, Nathan A, Bexton R, Camm A. Response of an abnormal sinus node to intravenous flecainide acetate. Pacing and Clinical Electrophysiology 7: 436–439, 1984
Hoffman B, Rosen M, Wit A. Electrophysiology and pharmacology of cardiac arrhythmias. VIII. Cardiac effects of quinidine and procaine amide. American Heart Journal 90: 117–122, 1975
Imamura T, Koiwaya Y, Nakamura M. Sinoatrial block induced by oral diltiazem. Clinical Cardiology 9: 33–34, 1986
Jordan J, Yamaguchi I, Mandel W. Studies on the mechanism of sinus node dysfunction in the sick sinus syndrome. Circulation 57: 217–223, 1978
Jose A, Collison D. The normal range and determinants of the intrinsic heart rate in man. Cardiovascular Research 4: 160–167, 1970
Kawai C, Konishi T, Matsuyama E, Okazaki H. Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on sinoatrial and atrioventricular nodes. Circulation 63: 1035–1042, 1981
Kulbertus H, de Leval-Rutten F, Demoulin J. Sino-atrial disease: a report on 13 cases. Journal of Electrocardiology 6: 303–312, 1973
Lippestad C, Forfgang K. Production of sinus arrest by lignocaine British Medical Journal 1: 537, 1971
McGovern B, Garan H, Kelly E, Ruskin J. Adverse reactions during treatment with amiodarone hydrochloride. British Medical Journal 287: 175–180, 1983
Medvedowsky J, Barnay C. Clinical relevance of sinus node function studies in humans. In Touboul P, Waldo A (Eds) Atrial arrhythmias: current concepts and management, pp. 330–339, Mosby Year Book Inc., Missuori, 1990
Montalescot G, Levy Y, Hatt P. Serious sinus node dysfunction caused by therapeutic doses of lithium. International Journal of Cardiology 5: 94–96, 1984
Petersen P, Boysen G, Godtfredsen J, Andersen E, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study. Lancet 1: 175–179, 1989
Petersen P, Gotfredsen J. Embolic complications in paroxysmal atrial fibrillation. Stroke 17: 622–626, 1986
Raviele A, Di Pede F, Zanocco A, Zuin G, Facin G, et al. Valore predittivo del test all’ajmalina nelle disfunzioni del nodo del seno. Giornale Italiano di Cardiologia 15: 751–760, 1985
Roos J, Paalman A, Dunning A. Electrophysiological effects of mexiletine in man. British Heart Journal 38: 1262–1271, 1976
Rosenqvist M, Brandt J, Schuller H. Atrial versus ventricular pacing in sinus node disease: a treatment comparison study. American Heart Journal 111: 292–297, 1986
Rosenqvist M, Brandt J, Schuller H. Long-term pacing in sinus node disease: Effects of stimulation mode on cardiovascular morbidity and mortality. American Heart Journal 116: 16–22, 1988
Rosenqvist M, Obel I. Atrial pacing and the risk of AV block: is there a time for change in attitude. Pacing and Clinical Electrophysiology 12: 97–101, 1989
Rubenstein J, Schulman C, Yurchak P, DeSanctis R. Clinical spectrum of the sick sinus syndrome. Circulation 46: 5–13, 1972
Santini M, Alexidou G, Ansalone G, Cacciattore G, Cini R, et al. Relation of prognosis in sick sinus syndrome to age, conduction defects and modes of permanent cardiac pacing. American Journal of Cardiology 65: 729–735, 1990
Sasaki S, Takeuchi A, Ohzeki M, Kishida H, Nishimoto T, et al. Long-term follow-up of paced patients with sick sinus syndrome. In Steinbach K (Ed.) Cardiac Pacing. Proceedings of the VIIIth World Symposium on Cardiac Pacing, pp. 85–90, Steinkopff Verlag, Darmstadt, 1983
Shaw D, Holman R, Gowers J. Survival in sinoatrial disorder (sick sinus syndrome). British Medical Journal 280: 139–141, 1980
Shaw D, Linker N, Heaver P, Evans R, Chronic sinoatrial disorder (sick sinus syndrome): a possible result of cardiac ischaemia. British Heart Journal 58: 598–607, 1987
Simoons M, Hugenholtz P. Haemodynamic effects of alinidine, a specific sinus node inhibitor, in patients with unstable angina and myocardial infarction. European Heart Journal 5: 227–232, 1984
Strauss H, Gilbert M, Svenson R, Miller H, Wallace A. Electrophysiologic effects of propanolol on sinus node function in patients with sinus node dysfunction. Circulation 54: 452–459, 1976
Stroke Prevention in Atrial Fibrillation Study Group Investigators. Preliminary report of the stroke prevention in atrial fibrillation study. New England Journal of Medicine 322: 863–868, 1990
Sutton R, Kenny R.-A. The natural history of sick sinus syndrome. Pacing and Clinical Electrophysiology 9: 1110–1114, 1986
The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. New England Journal of Medicine 323: 1505–1511, 1990
Touboul P, Atallah G, Gressard A, Kirkorian G. Effects of amiodarone on sinus node in man. British Heart Journal 42: 573–578, 1979
Tseu F, Morley C, MacKintosh A. Oral xamoterol in patients with sinoatrial disease. British Heart Journal 56: 469–472, 1986
Vera Z, Miller R, McMillin D, Mason D. Effects of digitalis on sinus node function in patients with sick sinus syndrome. American Journal of Cardiology 41: 318–323, 1978
Viersma J, van den Berg M, van Gilst W, Lie K. Intrinsic sympathomimetic activity (ISA) of pindolol in patients with sinus node dysfunction. European Heart Journal 7: 42–46, 1986
Wolf P, Dawber T, Thomas H, Kannel W. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 28: 973–977, 1978
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sneddon, J.F., Camm, A.J. Sinus Node Disease. Drugs 44, 728–737 (1992). https://doi.org/10.2165/00003495-199244050-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199244050-00005